Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina

  • Carrero, Laura
  • Antequera, Desireé
  • Alcalde, Ignacio
  • Megías, Diego
  • Ordóñez-Gutiérrez, Lara
  • Gutiérrez, Cristina
  • Merayo-Lloves, Jesús
  • Wandosell, Francisco
  • Municio, Cristina
  • Carro, Eva
Alzheimer’s disease (AD), the most prevalent form of dementia, is a neurodegenerative disorder characterized by different pathological symptomatology, including disrupted circadian rhythm. The regulation of circadian rhythm depends on the light information that is projected from the retina to the suprachiasmatic nucleus in the hypothalamus. Studies of AD patients and AD transgenic mice have revealed AD retinal pathology, including amyloid-β (Aβ) accumulation that can directly interfere with the regulation of the circadian cycle. Although the cause of AD pathology is poorly understood, one of the main risk factors for AD is female gender. Here, we found that female APP/PS1 mice at 6- and 12-months old display severe circadian rhythm disturbances and retinal pathological hallmarks, including Aβ deposits in retinal layers. Since brain Aβ transport is facilitated by aquaporin (AQP)4, the expression of AQPs were also explored in APP/PS1 retina to investigate a potential correlation between retinal Aβ deposits and AQPs expression. Important reductions in AQP1, AQP4, and AQP5 were detected in the retinal tissue of these transgenic mice, mainly at 6-months of age. Taken together, our findings suggest that abnormal transport of Aβ, mediated by impaired AQPs expression, contributes to the retinal degeneration in the early stages of AD., This study was supported by Carro grants from the Instituto de Salud Carlos III (PI2021/00679, PI22CIII/00042), FEDER, and CIBERNED (CB05/06/0022, PI2021/03), and by Wandosell grants from Ministry of Science, Innovation (I+D+i-RETOS-PID2021-124801NB-I00), and CIBERNED (CB05/06/0067)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Clearance of ß-amyloid mediated by autophagy is enhanced by MTORC1 inhibition but not AMPK activation in APP/PSEN1 astrocytes

  • García-Juan, Marta
  • Ordóñez-Gutiérrez, Lara
  • Wandosell, Francisco
Proteostasis mechanisms mediated by macroautophagy/autophagy are altered in neurodegenerative diseases such as Alzheimer disease (AD) and their recovery/enhancement has been proposed as a therapeutic approach. From the two central nodes in the anabolism-catabolism balance, it is generally accepted that mechanistic target of rapamycin kinase complex 1 (MTORC1)_ activation leads to the inhibition of autophagy, whereas adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) has the opposite role. In AD, amyloid beta (Aß) production disturbs the optimal neuronal/glial proteostasis. As astrocytes are essential for brain homeostasis, the purpose of this work was to analyze if the upregulation of autophagy in this cell type, either by MTORC1 inhibition or AMPK activation, could modulate the generation/degradation of ß-amyloid. By using primary astrocytes from amyloid beta precursor protein (APP)/Presenilin 1 (PSEN1) mouse model of AD, we confirmed that MTORC1 inhibition reduced Aß secretion through moderate autophagy induction. Surprisingly, pharmacologically increased activity of AMPK did not enhance autophagy but had different effects on Aß secretion. Conversely, AMPK inhibition did not affect autophagy but reduced Aß secretion. These puzzling data were confirmed through the overexpression of different mutant AMPK isoforms: while only the constitutively active AMPK increased autophagy, all versions augmented Aß secretion. We conclude that AMPK has a significantly different role in primary astrocytes than in other reported cells, similar to our previous findings in neurons. Our data support that perhaps only a basal AMPK activity is needed to maintain autophagy whereas the increased activity, either physiologically or pharmacologically, has no direct effect on autophagy-dependent amyloidosis. These results shed light on the controversy about the therapeutic effect of AMPK activation on autophagy induction., PI2016/01/Spanish FEDER/Science and Innovation Ministry PID2021-124801NB-I00/Spanish FEDER/Science and Innovation Ministry Proyectos I+D+i-RETOS-PID2021-124801NB-I00/Spanish FEDER/Science and Innovation Ministry I+D+i-RETOS-RTI2018-096303-B-C1/Spanish FEDER/Science and Innovation Ministry FPU18/05727/Spanish FEDER/Science and Innovation Ministry Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Fundación Ramón Areces and Banco Santander
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity

  • Villa-González, Mario
  • Rubio, Marina
  • Martín-López, Gerardo
  • Mallavibarrena, Paula R
  • Vallés-Saiz, Laura
  • Vivien, Denis
  • Wandosell, Francisco
Ischemic stroke is a sudden and acute disease characterized by neuronal death, increment of reactive gliosis (reactive microglia and astrocytes), and a severe inflammatory process. Neuroinflammation is an early event after cerebral ischemia, with microglia playing a leading role. Reactive microglia involve functional and morphological changes that drive a wide variety of phenotypes. In this context, deciphering the molecular mechanisms underlying such reactive microglial is essential to devise strategies to protect neurons and maintain certain brain functions affected by early neuroinflammation after ischemia. Here, we studied the role of mammalian target of rapamycin (mTOR) activity in the microglial response using a murine model of cerebral ischemia in the acute phase. We also determined the therapeutic relevance of the pharmacological administration of rapamycin, a mTOR inhibitor, before and after ischemic injury. Our data show that rapamycin, administered before or after brain ischemia induction, reduced the volume of brain damage and neuronal loss by attenuating the microglial response. Therefore, our findings indicate that the pharmacological inhibition of mTORC1 in the acute phase of ischemia may provide an alternative strategy to reduce neuronal damage through attenuation of the associated neuroinflammation., This work was supported by grants from the Spanish FEDER/Science and Innovation Ministry I + D + i-RETOS-PID2021-124801NB-I00, I + D + i-RETOS-PID2021-124801NB-I00, I + D + i-RETOS PID2020-115876GB-I00 and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED; an initiative of the ISCIII) [PI2016/01]. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged by FW (CBMSO). M.V.G was supported by a EMBO short-term fellowship (8665). G.M.L was supported by a Tatiana Pérez de Guzmán el Bueno fellowship 2021.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell adhesion and migration in disease: translational and therapeutic opportunities

  • Anderson, Kurt
  • Calle-Patino, Yolanda
  • Ivetic, Aleksandar
  • Parsons, Maddy
  • Valderrama, Ferran
  • Wells, Claire
  • Anton, Ines
In September 2023 members of the cell adhesion and cell migration research community came together to share their latest research and consider how our work might be translated for clinical practice. Alongside invited speakers, selected speakers and poster presentations, the meeting also included a round table discussion of how we might overcome the challenges associated with research translation. This meeting report seeks to highlight the key outcomes of that discussion and spark interest in the cell adhesions and cell migration research community to cross the perceived valley of death and translate our work into therapeutic benefit., Meeting was supported by funding from the Company of Biologists, grant No EA782 (to YC-P). Funded by Ministerio de Ciencia, Innovacion y Universidades MCIU/AEI/10.13039/501100011033 grant PID2021-124801NB-I00 (to IMA), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multifaceted role of the actin-binding protein WIP: Promotor and inhibitor of tumor progression and dissemination

  • Alonso-Eiras, Jorge
  • Antón, Inés María
Cancer cells depend on actin cytoskeleton reorganization to achieve hallmark malignant functions including abnormal activation, proliferation, migration and invasiveness. (Neural)-Wiskott-Aldrich Syndrome protein ((N-)WASP) binds actin and forms a complex with the WASP-interacting protein (WIP), which plays a critical role in regulating the actin cytoskeleton, through (N)-WASP-dependent and independent functions. Mutations in the WIP gene (WIPF1) lead to severe early onset immunodeficiency in humans and severe autoimmunity and shortened lifespan in mice. This review covers the available evidence about the physiological role of WIP in different tissues and its contribution to human disease, focusing on cancer. In solid tumors overexpression of WIP has mostly been associated with tumor initiation, progression and dissemination through matrix degradation by invadopodia, while a suppressive function has been shown for WIP in certain hematological cancers. Interestingly, a minority of studies suggest a protective role for WIP in specific tumor contexts. These data support the need for further research to fully understand the mechanisms underlying WIP's diverse functions in health and disease and raise important questions for future work., This work was supported by funding from MCIU/AEI/10.13039/501100011033 to IMA (PID2021-124801NB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Transcriptomic alterations in APP/PS1 mice astrocytes lead to early postnatal axon initial segment structural changes

  • Benitez, María José
  • Retana, Diana
  • Ordoñez-Gutiérrez, Lara
  • Colmena, Inés
  • Goméz, María José
  • Álvarez, Rebeca
  • Ciorraga, María
  • Dopazo, Ana
  • Wandosell, Francisco
  • Garrido, Juan José
Alzheimer´s disease (AD) is characterized by neuronal function loss and degeneration. The integrity of the axon initial segment (AIS) is essential to maintain neuronal function and output. AIS alterations are detected in human post-mortem AD brains and mice models, as well as, neurodevelopmental and mental disorders. However, the mechanisms leading to AIS deregulation in AD and the extrinsic glial origin are elusive. We studied early postnatal differences in AIS cellular/molecular mechanisms in wild-type or APP/PS1 mice and combined neuron-astrocyte co-cultures. We observed AIS integrity alterations, reduced ankyrinG expression and shortening, in APP/PS1 mice from P21 and loss of AIS integrity at 21 DIV in wild-type and APP/PS1 neurons in the presence of APP/PS1 astrocytes. AnkyrinG decrease is due to mRNAs and protein reduction of retinoic acid synthesis enzymes Rdh1 and Aldh1b1, as well as ADNP (Activity-dependent neuroprotective protein) in APP/PS1 astrocytes. This effect was mimicked by wild-type astrocytes expressing ADNP shRNA. In the presence of APP/PS1 astrocytes, wild-type neurons AIS is recovered by inhibition of retinoic acid degradation, and Adnp-derived NAP peptide (NAPVSIPQ) addition or P2X7 receptor inhibition, both regulated by retinoic acid levels. Moreover, P2X7 inhibitor treatment for 2 months impaired AIS disruption in APP/PS1 mice. Our findings extend current knowledge on AIS regulation, providing data to support the role of astrocytes in early postnatal AIS modulation. In conclusion, AD onset may be related to very early glial cell alterations that induce AIS and neuronal function changes, opening new therapeutic approaches to detect and avoid neuronal function loss., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was carried out with the following funding sources: Grant PID2021-123140NB-I00 to J.J.G. and PID2021-124801NB-I00 to FW funded by MCIN/AEI/https://doi. org/10.13039/501100011033, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBER-ISCIII) Grant PI2016/01., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HIF-1α downregulates the APP protein after oxygen and glucose deprivation in the APPswe/PSEN1 mouse model of Alzheimer’s disease

  • Villa-González, Mario
  • García-Juan, Marta
  • Ordóñez-Gutiérrez, Lara
  • Pérez-Álvarez, María José
  • Jurado, Francisco Wandosell
The mTORC1 and AMPK signalling pathways are considered key nodes regulating anabolism and catabolism, and they are altered in certain processes of neurodegeneration such as hypoxia associated with ischemic stroke or Alzheimer's disease. The lack of oxygen and/or glucose (oxygen and glucose deprivation-OGD) may affect the equilibrium of the mTORC1/AMPK pathways, perhaps aggravating neurodegeneration. The alteration of these pathways mediated by OGD may be reflected in other alterations, such as the activation of autophagy that could in turn modify the secretion/accumulation of amyloid-β, one of the two histopathological markers of Alzheimer's disease. Accordingly, we set out to analyze whether OGD enhances autophagy and its implication in neuronal amyloidosis. The data obtained reveal that OGD significantly dampens not only neuronal amyloid-β production but also, the total APP protein levels, without affecting BACE-1 levels. We show that this mechanism is independent of cellular proteolysis (autophagy or proteasome) and that it can be partially recovered by inhibiting HIF-1α activity., This work was supported by grants from the Spanish FEDER/Science and Innovation Ministry Proyectos I + D + i-RETOS-PID2021-124801NB-I00 and I + D + i-RETOS-PID2020-115876 GB-I00, This work was supported by grants from the Spanish FEDER/Science and Innovation Ministry Proyectos I + D + i-RETOS-PID2021-124801NB-I00, (FW) and I + D + i-RETOS-PID2020-115876 GB-I00 (MJP). This work was partially supported by Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED; an initiative of the ISCIII) [PI2016/01] (FW); and institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO. In addition, MGJ was supported by a Predoctoral fellowship (Ref #FPU18/05727) and LO was initially supported by a Postdoctoral Contract from CIBERNED., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reassessing the AMPK-MTORC1 balance in autophagy in the central nervous system

  • García-Juan, Marta
  • Villa, Mario
  • Benito-Cuesta, Irene
  • Ordóñez-Gutiérrez, Lara
  • Wandosell, Francisco
Autophagy is a cellular degradation and recycling system, indispensable for cellular and organ development, homeostasis, and function. This cellular process is evolutionarily highly conserved to quality control of many proteins and dysfunctional organelles, which finally recycle components as amino acids. This process is effective during normal physiology as part of anabolism and plays an additional important role during starvation (Dikic and Elazar, 2018). Different types of autophagy have been characterized based on their dynamic, mechanism of action, target substrates, and protein markers. Some of them are macroautophagy (hereafter called “autophagy”), microautophagy, and chaperone-mediated autophagy (Fleming et al., 2022)., This work was supported by Grants from Spanish FEDER/Science and Innovation Ministry I + D + i-RETOS-PID2021-124801NB-I00; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED; an initiative of the ISCIII) [PI2016/01]; and institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO (to FW).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

R-Ras1 and R-Ras2 regulate mature oligodendrocyte subpopulations

  • Alcover-Sanchez, Berta
  • Garcia-Martin, Gonzalo
  • Paleo-García, Víctor
  • Quintas, Ana
  • Dopazo, Ana
  • Gruart, Agnès
  • Delgado-García, José María
  • de la Villa, Pedro
  • Wandosell, Francisco
  • Pereira, Marta P.
  • Cubelos, Beatriz
In the mammalian central nervous system, axonal myelination, executed by mature oligodendrocytes (MOLs), enables rapid neural transmission. Conversely, myelin deficiencies are hallmark features of multiple sclerosis, optic neuromyelitis, and some leukodystrophies. Recent studies have highlighted that MOLs are heterogeneous; however, how MOL subpopulations are specified and balanced in physiological settings is poorly understood. Previous works have demonstrated an essential role of the small GTPases R-Ras1 and R-Ras2 in the survival and myelination of oligodendrocytes. In this study, we aimed to determine how R-Ras1 and R-Ras2 contribute to the heterogeneity of MOL subpopulations. Our results evidence that R-Ras1 and R-Ras2 affect specification into the distinct subpopulations MOL1, MOL2, and MOL5/6, which in turn vary in their dependence of these GTPases. In R-Ras1 and/or R-Ras2 mutant mice, we observed an increase in the MOL1 subpopulation and a decrease in the MOL2 and MOL5/6 subpopulations. We identified R-Ras1 and R-Ras2 as key elements in balancing the heterogeneity of MOLs. Our results contribute to the understanding of the molecular mechanisms underlying the heterogeneity of MOLs and the myelination processes, which is crucial for innovating regenerative therapies for nervous system disorders., Ministerio de Ciencia, Innovación y Universidades. Spain, Grant/Award Numbers: PID2020-118189RB-I00, PID2021-1232690B-I00, PID2021-124801NB-I00
e-cienciaDatos, Repositorio de Datos del Consorcio Madroño
Datos de investigación Set de datos (Dataset)

Pharmacological inhibition of mTORC1 reduces neural death and damage volumen after MCAO by modulating microglial reactivity

  • Villa González, Mario
  • Rubio, Marina
  • Martín López, Gerardo
  • R. Mallavibarrena, Paula
  • Vallés Saiz, Laura
  • VIVIEN, DENIS
  • Wandosell, Francisco
  • Perez Alvarez, Maria Jose
<p>Ischemic stroke is a sudden and acute disease characterized by neuronal death, increment of reactive gliosis (reactive microglia and astrocytes), and a severe inflammatory process. Neuroinflammation is an early event after cerebral ischemia, with microglia playing a leading role. Reactive microglia involve functional and morphological changes that drive a wide variety of phenotypes. In this context, deciphering the molecular mechanisms underlying such reactive microglial is essential to devise strategies to protect neurons and maintain certain brain functions affected by early neuroinflammation after ischemia. Here, we studied the role of mammalian target of rapamycin (mTOR) activity in the microglial response using a murine model of cerebral ischemia in the acute phase. We also determined the therapeutic relevance of the pharmacological administration of rapamycin, a mTOR inhibitor, before and after ischemic injury. Our data show that rapamycin, administered before or after brain ischemia induction, reduced the volume of brain damage and neuronal loss by attenuating the microglial response. Therefore, our findings indicate that the pharmacological inhibition of mTORC1 in the acute phase of ischemia may provide an alternative estrategia to reduce neuronal damage through attenuation of the associated neuroinflammation.</p> <p>This dataset contains the raw data of cuantificación used in this study. It includes all the observations and measurements that were collected, which are essential for analysis and interpretation. The data is organized in a way that facilitates further exploration and analysis, ensuring that researchers can effectively utilize it for their own studies.</p>
Docta Complutense
Publicación Artículo científico (JournalArticle)

Clearance of β‐amyloid mediated by autophagy is enhanced by MTORC1 inhibition but not AMPK activation in APP/PSEN1 astrocytes

  • García‐Juan, Marta
  • Ordóñez Gutiérrez, Lara
  • Wandosell, Francisco
Abstract: Proteostasis mechanisms mediated by macroautophagy/autophagy are altered in neurodegenerative diseases such as Alzheimer disease (AD) and their recovery/enhancement has been proposed as a therapeutic approach. From the two central nodes in the anabolism–catabolism balance, it is generally accepted that mechanistic target of rapamycin kinase complex 1 (MTORC1)_ activation leads to the inhibition of autophagy, whereas adenosine 5′‐monophosphate (AMP)‐activated protein kinase (AMPK) has the opposite role. In AD, amyloid beta (Aβ) production disturbs the optimal neuronal/glial proteostasis. As astrocytes are essential for brain homeostasis, the purpose of this work was to analyze if the upregulation of autophagy in this cell type, either by MTORC1 inhibition or AMPK activation, could modulate the generation/degradation of β‐amyloid. By using primary astrocytes from amyloid beta precursor protein (APP)/Presenilin 1 (PSEN1) mouse model of AD, we confirmed that MTORC1 inhibition reduced Aβ secretion through moderate autophagy induction. Surprisingly, pharmacologically increased activity of AMPK did not enhance autophagy but had different effects on Aβ secretion. Conversely, AMPK inhibition did not affect autophagy but reduced Aβ secretion. These puzzling data were confirmed through the overexpression of different mutant AMPK isoforms: while only the constitutively active AMPK increased autophagy, all versions augmented Aβ secretion. We conclude that AMPK has a significantly different role in primary astrocytes than in other reported cells, similar to our previous findings in neurons. Our data support that perhaps only a basal AMPK activity is needed to maintain autophagy whereas the increased activity, either physiologically or pharmacologically, has no direct effect on autophagy‐dependent amyloidosis. These results shed light on the controversy about the therapeutic effect of AMPK activation on autophagy induction.</jats:p>